EB-201 (Estrella Immunopharma)

N/A

Report date: 2025/02/07 12:00:17

Base Information

Drug NameEB-201 (Estrella Immunopharma)
Drug Alias NameEB-201EB201
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEstrella Immunopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesEstrella Immunopharma Inc
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A